ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FORMA Therapeutics receives FDA orphan drug designation for FT-4202 to treat sickle cell disease pharmaceutical-business-review
April 20, 2020FORMA Therapeutics, a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers. -
Ubiquigent, Forma Therapeutics collaborate for DUB inhibitors
biospectrumasia
April 08, 2018The collaboration builds on an existing long term relationship between the parties whereby FORMA has accessed Ubiquigent’s DUBprofiler? platform for the screening of test compounds -
Ubiquigent, Forma Therapeutics collaborate for DUB inhibitors
biospectrumasia
April 08, 2018The collaboration builds on an existing long term relationship between the parties whereby FORMA has accessed Ubiquigent’s DUBprofiler? platform for the screening of test compounds -
FORMA Therapeutics Collaborates with Arpeggio Biosciences to Explore Translational Utility of Drug Candidates
biospace
March 27, 2018?FORMA Therapeutics?and Arpeggio Biosciences today announced a collaboration to utilize Arpeggio Biosciences’ proprietary technology to supplement FORMA’s analysis of the biological effects of its potential drug candidates.
Pharma Sources Insight January 2025
